Ridgewood Investments’s AstraZeneca AZN Stock Holding History

Ridgewood Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-356	Closed	-$49.7K	–	235
2025 Q2	$49.7K	Hold	356	–	–	0.02%	331
2025 Q1	$52.3K	Hold	356	–	–	0.02%	310
2024 Q4	$46.7K	Sell	356 -37	-9%	-$5.18K	0.02%	320
2024 Q3	$61.2K	Sell	393 -61	-13%	-$9.85K	0.03%	288
2024 Q2	$70.7K	Buy	+454	New	+$68.3K	0.04%	273
2023 Q3	–	Sell	-405	Closed	-$57.9K	–	222
2023 Q2	$57.9K	Sell	405 -21	-5%	-$3.09K	0.03%	308
2023 Q1	$59.1K	Buy	+426	New	+$57.3K	0.04%	315

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ridgewood Investments's AZN Position: Q3 2025 in Review

Ridgewood Investments sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 356 shares — an estimated $49.7K sold.

Ridgewood Investments first reported a position in AZN in Q1 2023 and held it in 7 quarters. The position peaked at $70.7K in Q2 2024. 1,289 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Ridgewood Investments reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
Ridgewood Investments sold 356 AstraZeneca shares in Q3 2025, an estimated $49.7K.
Ridgewood Investments first reported a position in AstraZeneca in Q1 2023 and held it in 7 quarters.
Ridgewood Investments's AstraZeneca position peaked at $70.7K in Q2 2024.
1,289 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.